Patent · US Active

Opioid agonist peptides and uses thereof

US10729676B2 · kind B2 · utility

8Cited by

41References

18Claims

0Family size

Assignee

Protagonist Therapeutics, Inc. · US

Inventors

Sampath-Kumar Anandan · Fremont, US
Jie Zhang · Beijing, CN
Ashok Bhandari · Pleasanton, US
Gregory Thomas Bourne · Jindalee, AU
Brian Troy Frederick · Arlanza, US
Larry C. Mattheakis · Cupertino, US
David Liu · Palo Alto, US
Mukund Mehrotra · South San Francisco, US

Key dates

Filing date	Mar 6, 2019
Grant date	Aug 4, 2020
Priority date	—
Expiry date	Mar 6, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K7/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention is directed to opioid agonist peptides and their use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.